Viewing Study NCT06838832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-01-31 @ 7:45 PM
Study NCT ID: NCT06838832
Status: RECRUITING
Last Update Posted: 2025-07-30
First Post: 2025-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL
Sponsor: Chinese PLA General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-hodgkin Lymphoma,B Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell malignancies View
None Relapsed or refractory View
None allogeneic CD19-CAR-γδT View
None gene editing View